Medusa 19 was born from a need to respond to the COVID-19 pandemic, providing an innovative solution that can help everyone get back to normal.
With extensive experience in worldwide logistics, delivery, e-commerce, supply chains and fulfilment co-founders Richard Hughes and Mahmud Kamani, founders of boohoo, sought to deliver a solution to restore trust, reduce impact on businesses and put people back in control of their day-to-day lives.
As Trusted by
Meet The Team
Andy has significant experience as a CFO within the product distribution sector. He spent 17 years within the telecoms distribution sector within the fast growing Caudwell Group and latterly 2020 Mobile Group after the sale of the business to two Private Equity businesses in 2006.
Andy has a track record in value creation within the private equity environment both at a cycling distribution business, Fisher Outdoor Leisure, on behalf of Living Bridge Private Equity and then Chargepoint Technology, a containment solution provider in the pharmaceutical industry.
Andy has been responsible for building the necessary functions that will enable the saliva tests to be rapidly and globally deployed. Part of his remit going forward will be liaising and dealing with the Government Agencies and large enterprises for distribution contracts across the world
Andy is a qualified Chartered Accountant.
Chief Development Officer
Christian Stephenson has over 24 years experience in the medical devices industry. Working for a range of multinational blue-chip companies (Smith&Nephew, KCI, 3M ) and start-up / SME’s (Crawford Health Care & Lantor). His career has primarily focussed on R&D and strategic portfolio development, and building teams with market-leading track records of delivery. Christian’s last role was Vice President of R&D for KCI, the largest wound care company globally, where he was responsible for the whole wound care pipeline and global R&D team. Prior to this position, Christian led the R&D, Regulatory and Quality team at Crawford Healthcare, developing from scratch a wound care portfolio, which rapidly became the 3rd largest in the UK, with Kerrmax becoming the number 1 brand in the medical device market. Christian was part of the management team that ultimately led to the successful sale of Crawford.
Christian holds a degree in Chemistry from the University of Hull and has numerous publications and patents.
Stuart is an ACA qualified Chartered Accountant. Stuart has over 10 years of senior financial and operational management within manufacturing of cGMP pharmaceutical grade facilities. Extensive experience in high growth and start up enterprises including manufacturing, hospitality, sport, leisure and construction businesses.
Stuart holds a Masters in Chemistry from Sheffield University
Sourcing and Procurement Director
Frank has successfully managed and delivered new product roadmaps and strategy across the Medical sector over the last 20 years. Senior consultancy positions held at 3M, KCI Acelity, Crawford Pharmaceuticals, DOH and NHS Pensions and several large IT and Telco blue chip companies has enabled a vast reach into securing Manufacturing scale out, Regulatory Compliance and Technology Innovation.
Global Sales Director
Stuart has an extensive background in international business development. With a strong history in supplying scientific and technical solutions for governments and private industry including civil engineering and the oil & gas sectors, Stuart founded Northeastern Geophysical Ltd whose core business lies within supplying seismic monitoring solutions and analysis services to private industry clients globally. In his previous positions, Stuart has built and managed international distribution networks across the Americas, Europe, Asia and Australasia, creating a seamless operation for goods and services to be positioned globally.
Stuart holds a BSc in Earth Sciences from University of Glasgow.
"At Brown & Newirth, the wellbeing of our employees always comes first. As such, finding a COVID-19 testing solution that could ensure their safety as well as enable us to continue servicing our customers was our priority. A number of testing providers were looked into and considered. We ultimately decided on Medusa 19’s Rapid Saliva Protein Test, based on it being easy-to-use, non-invasive, provide results quickly and 94% accuracy, ensuring business interruption is kept to a minimum."
John Ball, MD Brown & Newirth
"CPI Books is one of the major players in the printing market in Europe. With the impact of COVID-19 our priority was the safety and welfare of our workforce. We needed to look after over 2,500 employees and keep the company fully operational across its sites. We reviewed a number of COVID-19 test options that were available to us at the scale, frequency and costs we needed. We successfully trialled Medusa 19’s Rapid Salvia Protein Test across carefully targeted areas of our business – as a result we are confident the tests will support the business in operating effectively and safely across our sites."
"When an increasing number of our clients began to ask for rapid COVID screening services, our priority was to find a solution that we believed worked best for their needs: quick and reliable results, a transparent supply chain and a test that would be simple for our testing professionals to administer in workplace settings. We chose to work with Medusa 19 as it can provide kits on a wide scale, it works closely with the researchers who developed the test so can provide guidance reliably, and the company understood Lemon Cherry’s needs – and those of our clients."
Jonathan Smith, MD Lemon Cherry
Ready to Get Back on Track?
Get back to normal with our testing solutions perfect for businesses of any size. Get in touch with our experts to see how we can help to rebuild confidence in your workplace.